William

I, William Auriemma, nominated by and residing in The United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I serve as the Chie Executive Officer of Diversified CPC International, Inc., engaged in the supply of aerosol propellants to the consumer products industry. We do extensive work in determining commercial viability of “next generation” of propellant systems. My role as Past Chairman of the Household & Commercial Products Association allows for direct interaction with U.S. regulatory agencies.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests , and those of my personal partner and dependents, include the following:
   • Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies.
   • Financial interests: I do not ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: My company works closely with major U.S. based manufacturers of low GWP substances and is the marketing and distribution arm of these products to the aerosol and medical device industries.
   • Government advice and other policy development: See above under Item c.
   • Paid research activities, fellowships or grants: None.
   • Other interests:
5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee is our company, Diversified CPC International, Inc. and they will bear all related costs.  There are no consulting fees involved.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have declined to disclose information falling within paragraph 10 of those Guidelines and I undertake to ensure that I am completely excluded from discussion and decisions on topics related to the information that I have declined to disclose. 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: William Auriemma
Date: 19th April 2021